Drug Therapies against Acute Respiratory Distress: A Critical Endpoint of COVID-19-Reference-Cited by-同舟云学术

Drug Therapies against Acute Respiratory Distress: A Critical Endpoint of COVID-19

Published:2023-11-02 Issue: Volume: Page:110-149
ISSN:
Container-title:Medicinal Plants, Phytomedicines and Traditional Herbal Remedies for Drug Discovery and Development against COVID-19
language:
Short-container-title:

Author:

Salama Maha M.¹,Merghany Rana M.¹,Zayed Ahmed²,Salem Mohamed A.³,Ezzat Shahira M.¹

Affiliation:

1. Department of Pharmacognosy, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, Cairo 11562, Egypt

2. Department of Pharmacognosy, College of Pharmacy, Tanta University, Elguish street 31527, Tanta, Egypt

3. Department of Pharmacognosy, Faculty of Pharmacy, Menoufia University, Gamal Abd El Nasr st., ShibinElkom 32511, Menoufia, Egypt

Abstract

Pulmonary diseases have been increasing for decades, which are responsible for the high incidence of morbidity and mortality all over the world. Since the year 2019, the world suffers from coronavirus disease 2019 (COVID-19) which is caused by SARS-CoV-2 and it was classified as a pandemic respiratory disease by the World Health Organization (WHO). The problem of this virus is the lack of a medicine or a specific antivirus drug to combat it, so many approaches have been designed to protect the patients from its symptoms and side effect and also to raise the human innate immunity. Consequently, this chapter will provide an overview of herbs and their derived natural products which have anti-inflammatory, immunomodulatory, and anti-microbial activities which might be beneficial for the discovery of structurally-related compounds that can be candidate therapeutics alleviating the symptoms associated with acute respiratory diseases.

Publisher

BENTHAM SCIENCE PUBLISHERS

Reference179 articles.

1. Soriano J.B.; Kendrick P.J.; Paulson K.R.; Gupta V.; Abrams E.M.; Adedoyin R.A.; Adhikari T.B.; Advani S.M.; Agrawal A.; Ahmadian E.; Alahdab F.; Aljunid S.M.; Altirkawi K.A.; Alvis-Guzman N.; Anber N.H.; Andrei C.L.; Anjomshoa M.; Ansari F.; Antó J.M.; Arabloo J.; Athari S.M.; Athari S.S.; Awoke N.; Badawi A.; Banoub J.A.M.; Bennett D.A.; Bensenor I.M.; Berfield K.S.S.; Bernstein R.S.; Bhattacharyya K.; Bijani A.; Brauer M.; Bukhman G.; Butt Z.A.; Cámera L.A.; Car J.; Carrero J.J.; Carvalho F.; Castañeda-Orjuela C.A.; Choi J-Y.J.; Christopher D.J.; Cohen A.J.; Dandona L.; Dandona R.; Dang A.K.; Daryani A.; de Courten B.; Demeke F.M.; Demoz G.T.; De Neve J-W.; Desai R.; Dharmaratne S.D.; Diaz D.; Douiri A.; Driscoll T.R.; Duken E.E.; Eftekhari A.; Elkout H.; Endries A.Y.; Fadhil I.; Faro A.; Farzadfar F.; Fernandes E.; Filip I.; Fischer F.; Foroutan M.; Garcia-Gordillo M.A.; Gebre A.K.; Gebremedhin K.B.; Gebremeskel G.G.; Gezae K.E.; Ghoshal A.G.; Gill P.S.; Gillum R.F.; Goudarzi H.; Guo Y.; Gupta R.; Hailu G.B.; Hasanzadeh A.; Hassen H.Y.; Hay S.I.; Hoang C.L.; Hole M.K.; Horita N.; Hosgood H.D.; Hostiuc M.; Househ M.; Ilesanmi O.S.; Ilic M.D.; Irvani S.S.N.; Islam S.M.S.; Jakovljevic M.; Jamal A.A.; Jha R.P.; Jonas J.B.; Kabir Z.; Kasaeian A.; Kasahun G.G.; Kassa G.M.; Kefale A.T.; Kengne A.P.; Khader Y.S.; Khafaie M.A.; Khan E.A.; Khan J.; Khubchandani J.; Kim Y-E.; Kim Y.J.; Kisa S.; Kisa A.; Knibbs L.D.; Komaki H.; Koul P.A.; Koyanagi A.; Kumar G.A.; Lan Q.; Lasrado S.; Lauriola P.; La Vecchia C.; Le T.T.; Leigh J.; Levi M.; Li S.; Lopez A.D.; Lotufo P.A.; Madotto F.; Mahotra N.B.; Majdan M.; Majeed A.; Malekzadeh R.; Mamun A.A.; Manafi N.; Manafi F.; Mantovani L.G.; Meharie B.G.; Meles H.G.; Meles G.G.; Menezes R.G.; Mestrovic T.; Miller T.R.; Mini G.K.; Mirrakhimov E.M.; Moazen B.; Mohammad K.A.; Mohammed S.; Mohebi F.; Mokdad A.H.; Molokhia M.; Monasta L.; Moradi M.; Moradi G.; Morawska L.; Mousavi S.M.; Musa K.I.; Mustafa G.; Naderi M.; Naghavi M.; Naik G.; Nair S.; Nangia V.; Nansseu J.R.; Nazari J.; Ndwandwe D.E.; Negoi R.I.; Nguyen T.H.; Nguyen C.T.; Nguyen H.L.T.; Nixon M.R.; Ofori-Asenso R.; Ogbo F.A.; Olagunju A.T.; Olagunju T.O.; Oren E.; Ortiz J.R.; Owolabi M.O.; P A M.; Pakhale S.; Pana A.; Panda-Jonas S.; Park E-K.; Pham H.Q.; Postma M.J.; Pourjafar H.; Poustchi H.; Radfar A.; Rafiei A.; Rahim F.; Rahman M.H.U.; Rahman M.A.; Rawaf S.; Rawaf D.L.; Rawal L.; Reiner R.C.; Reitsma M.B.; Roever L.; Ronfani L.; Roro E.M.; Roshandel G.; Rudd K.E.; Sabde Y.D.; Sabour S.; Saddik B.; Safari S.; Saleem K.; Samy A.M.; Santric-Milicevic M.M.; Sao Jose B.P.; Sartorius B.; Satpathy M.; Savic M.; Sawhney M.; Sepanlou S.G.; Shaikh M.A.; Sheikh A.; Shigematsu M.; Shirkoohi R.; Si S.; Siabani S.; Singh V.; Singh J.A.; Soljak M.; Somayaji R.; Soofi M.; Soyiri I.N.; Tefera Y.M.; Temsah M-H.; Tesfay B.E.; Thakur J.S.; Toma A.T.; Tortajada-Girbés M.; Tran K.B.; Tran B.X.; Tudor Car L.; Ullah I.; Vacante M.; Valdez P.R.; van Boven J.F.M.; Vasankari T.J.; Veisani Y.; Violante F.S.; Wagner G.R.; Westerman R.; Wolfe C.D.A.; Wondafrash D.Z.; Wondmieneh A.B.; Yonemoto N.; Yoon S-J.; Zaidi Z.; Zamani M.; Zar H.J.; Zhang Y.; Vos T.; GBD Chronic Respiratory Disease Collaborators. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med 2020 ,8(6),585-596

2. Máca J.; Jor O.; Holub M.; Sklienka P.; Burša F.; Burda M.; Janout V.; Ševčík P.; Past and Present ARDS Mortality Rates: A Systematic Review. Respir Care 2017 ,62(1),113-122

3. Han S.; Mallampalli R.K.; The acute respiratory distress syndrome: from mechanism to translation. J Immunol 2015 ,194(3),855-860

4. WHO. WHO Director-General’s remarks at the media briefing on 2019-nCoV. 2020 Available at: (Accessed on: 11 February 2020). https://wwwwhoint/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020

5. Bai Y.; Yao L.; Wei T.; Tian F.; Jin D.Y.; Chen L.; Wang M.; Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA 2020 ,323(14),1406-1407